Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial
Why the study?
Does beta-blocker treatment improve outcomes in patients after myocardial infarction without reduced ejection fraction?
Population
Patients after myocardial infarction without reduced ejection fraction
Design
RCT, Randomized
Authors
Discussion
Loading...
Member takes
Implication
This paper describes the design and rationale for a randomized controlled trial evaluating beta-blocker treatment in patients with myocardial infarction without reduced ejection fraction.
Structured PICO
Does beta-blocker treatment improve outcomes in patients after myocardial infarction without reduced ejection fraction?
P
Population
Patients after myocardial infarction without reduced ejection fraction
I
Intervention
Beta-blocker treatment
This paper describes the design and rationale for a randomized controlled trial evaluating beta-blocker treatment in patients with myocardial infarction without reduced ejection fraction.
Cite This Study
Kristensen et al. (2020) studied this question.